$OHRP Brean Capital Maintains Buy On OHR Pharmaceutical Following End Of Phase 2 Meeting With The FDA http://www.smarteranalyst.com/2014/10/14/brean-capital-maintains-buy-ohr-pharmaceutical-following-end-phase-2-meeting-fda/